Who We Are

The New Jersey Life Sciences Vendors Alliance (NJLSVA) is a coalition of businesses, individuals and academia who provide goods and services to New Jersey’s life sciences companies.

The NJLSVA was founded to educate suppliers on trends in industry procurement and public policy that affects the life sciences industry.

Choose NJ’s RFP Watch

Choose New Jersey’s RFP Watch provides up-to-date information on business opportunities throughout the Garden State at a cost that is affordable for all companies – with a place of business in New Jersey – large and small.

To learn more click here

HIV/AIDS

New Report: More Than 50 Medicines and Vaccines in Development for HIV Infection, Treatment and Prevention

Washington, DC, June 30, 2017 — The Pharmaceutical Research and Manufacturers of America (PhRMA) reports that America’s biopharmaceutical companies are continuing the fight to conquer the human immunodeficiency virus (HIV), which can develop into acquired immune deficiency syndrome (AIDS).

According to a new report released on June 27 by PhRMA in partnership with The AIDS Institute, 52 medicines and vaccines are currently in development to help treat and prevent the infection.

Among the 52 medicines in development for HIV, there are 32 antiretrovirals and antivirals, 16 vaccines and four cell therapies, including a potential first-in-class medicine intended to prevent HIV from attaching to new cells and breaking through the cell membrane. Continue reading

Rutgers Q&A: Dr. Perry Halkitis, Openly Gay Dean of Rutgers School of Public Health, Seeks to Shatter Perceptions, Improve LGBTQ Health

Dr. Perry Halkitis

New Brunswick, NJ, June 20, 2017 — When Perry N. Halkitis, Ph.D., the incoming dean at Rutgers School of Public Health, is asked to discuss the accomplishments that make him most proud, his research in HIV/AIDS, his mentorship of young scholars and practitioners, and his roles as senior associate dean of New York University’s College of Global Public Health and director of the Center for Health, Identity, Behavior and Prevention Studies come to the fore.

But equal to those achievements is Dr. Halkitis’ identity as an openly gay man in academia and a first-generation college student.

Halkitis, who will join Rutgers in August, is enthusiastic about furthering the research he pursued at NYU. Continue reading

Rutgers Names Dr. Perry N. Halkitis Dean of School of Public Health

Dr. Perry Halkitis

Piscataway, NJ, March 24, 2017 — Perry N. Halkitis, senior associate dean of New York University’s College of Global Public Health, has been named dean of the School of Public Health at Rutgers, The State University of New Jersey.

Dr. Halkitis is expected to join Rutgers in August 2017.

Dr. Halkitis is also professor of global public health, applied psychology and medicine and director of the Center for Health, Identity, Behavior and Prevention Studies at NYU, where he has focused a significant amount of his research on HIV/AIDS and drug abuse as well as the impact of psychiatric and psychosocial factors on mental health. Continue reading

New Jersey Department of Health Observes World AIDS Day 2016

world-aids-day-blackTrenton, NJ, December 1, 2016 — New Jersey will join the World Health Organization tomorrow, December 1, in observing World AIDS Day with events statewide organized to support individuals living with HIV infection, remember those who have died from the disease and encourage everyone to seek HIV testing to determine if they are infected.

This year’s theme is “Leadership. Commitment. Impact.”

As of June 30, 2016, more than 37,336 people were living with HIV or AIDS in New Jersey. It is estimated that about one in eight people living with HIV do not know they are infected. Continue reading

As International AIDS Conference Starts, A Cure for AIDS Is No Longer Unthinkable

AIDS CureWashington, DC, July 18, 2016 ― Lenny Bernstein reports in The Washington Post that not many years ago, the idea of defeating the resilient virus that causes AIDS was far-fetched.

But as 18,000 people gather this coming week in Durban, South Africa, for the 21st International AIDS Conference, the prospect of a cure is plausible enough that it is attracting increasing amounts of money, scientific research and attention.

Discussion of a cure will lead off the conference, which comes little more than a month after the United Nations committed to action to end the AIDS epidemic by 2030, despite formidable obstacles. Continue reading

NIH Expands Investment in HIV Cure Research; Six Research Teams to Lead Collaborative Investigations Worldwide

HIV AIDS research wordsBethesda, MD, July 17, 2016 — The National Institutes of Health (NIH) announced on July 13 that it has awarded approximately $30 million in annual funding over the next five years to six research collaborations working to advance basic medical science toward an HIV cure.

The awards comprise the second iteration of the Martin Delaney Collaboratory: Towards an HIV-1 Cure program and are a part of President Barack Obama’s pledge to invest in HIV cure research.

The research program is supported by the National Institute of Allergy and Infectious Diseases (NIAID), the National Institute on Drug Abuse, the National Institute of Mental Health, and the National Institute of Neurological Disorders and Stroke, all part of the NIH. Continue reading

HHS Awards $2.2 Billion in Ryan White Grants for HIV/AIDS Care And Medications

Ryan WhiteWashington, DC, October 21, 2015 — Health and Human Services Secretary Sylvia M. Burwell announced today that more than $2.2 billion in Ryan White HIV/AIDS Program grants was awarded in fiscal year (FY) 2015 to cities, states and local community-based organizations.

This funding supports a coordinated and comprehensive system of care to ensure that more than half a million people living with and affected by HIV in the United States continue to have access to critical HIV health care, support services, and essential medications.

The program is named in honor of the late Ryan White, who — along with his mother, Jeanne White Ginder — fought AIDS-related discrimination and helped educate the nation and world about his disease. Continue reading

HHS’s ‘Positive Spin’ Aims to Encourage HIV Prevention, Testing and Treatment

Washington, DC, March 25, 2015 ― The U.S. Department of Health and Human Services today released Positive Spin, a comprehensive digital educational tool that uses personal storytelling to promote the importance of getting people with HIV into treatment.

The project, which was developed by AIDS.gov with input from federal agencies, health care professionals, persons living with HIV and community-based HIV organizations, is available at https://positivespin.hiv.gov. Continue reading